Blood pressure management is one of the most common and important parts of my work as a Family Medicine physician. We have all heard hypertension called the “silent killer,” and although the phrase is overused, it remains accurate. High blood pressure usually causes no symptoms while gradually increasing the risk of heart attack, stroke, heart failure, kidney disease, atrial fibrillation, and cognitive decline.
Treatment often starts with lifestyle changes, including regular exercise, weight loss when appropriate, less dietary sodium, better sleep, and reducing alcohol. Sometimes that is enough. Other patients need medication, and many eventually need more than one.
What I do not like is medication without a clear purpose. When I review a patient’s medication list, I want to know why each drug is there, whether it is working, and whether it may be causing harm. “You’ve been taking it for years” is not a sufficient reason to continue something indefinitely. Good medicine includes starting medications when appropriate, but it also includes changing, reducing, and occasionally stopping them.
Here are five things I pay particular attention to when treating high blood pressure.
1. Down Goes the Beta-Blocker
I hunt down unnecessary beta-blockers like I’m a middle linebacker trying to tackle a running back.
Beta-blockers are not bad medications. They are valuable when prescribed for the right reason. The problem is that uncomplicated hypertension often is not that reason.
Medications such as metoprolol and atenolol were once used much more routinely as initial blood pressure treatment. The reasoning was understandable. Beta-blockers slow the heart rate, reduce the effects of adrenaline, and decrease how hard the heart has to work. All of that can lower blood pressure.
However, our goal is not simply to lower the number on the cuff. We are trying to prevent strokes, heart attacks, heart failure, kidney disease, and premature death. Compared with several other medication classes, traditional beta-blockers have generally not performed as well for uncomplicated hypertension, particularly for stroke prevention.
Current guidelines instead favor ACE inhibitors, angiotensin receptor blockers, thiazide-type diuretics, and long-acting calcium-channel blockers as first-line options. Beta-blockers remain appropriate for certain abnormal heart rhythms, angina, selected patients after a heart attack, heart failure with reduced ejection fraction, essential tremor, migraines, and several other conditions. The point is that there should be a reason for the medication to be there. [1,2]
Beta-blockers can also contribute to fatigue, dizziness, slow heart rate, reduced exercise tolerance, sexual side effects, sleep disturbance, and weight gain. If a patient feels exhausted, has difficulty exercising, has a resting heart rate in the low 50s, and no longer has a compelling indication for the medication, I am going to question whether it still belongs on the list.
Maybe they all end in “lol” because sometimes you have to laugh at how long they remain on medication lists without anyone asking why.
2. Half-Life Matters
Medical school is funny. We can spend hours learning the biochemical details of a disease we may encounter twice in our careers, then spend surprisingly little time discussing the practical pharmacology of medications we prescribe every day.
One important concept is a medication’s half-life, which is roughly the time it takes for the amount of that drug in the body to decrease by half. Half-life is not the only factor determining how long a medication works, but it matters. Hypertension exists throughout the entire day, so I generally prefer medications that provide reliable coverage throughout the day and night.
Losartan is a good example. It is probably the best-known member of the ARB family. It works, is inexpensive, and has been prescribed successfully for decades. That said, it is not always my favorite ARB.
Losartan itself has a relatively short half-life, although its active metabolite extends its blood-pressure-lowering effect. Telmisartan, by comparison, has a much longer terminal half-life and often provides more consistent coverage toward the end of the dosing interval.
That does not make losartan ineffective, nor does it make telmisartan the best choice for everyone. The dose, individual response, kidney function, potassium level, insurance coverage, other medical conditions, and potential side effects all matter. Some patients have excellent 24-hour control with losartan. Others look great several hours after taking it but see their blood pressure rise again before the next dose.
If I am choosing among medications in the same family, I consider how long each one lasts. I am not trying to create an impressive reading two hours after someone takes a pill. I want reliable control for the entire day.
3. Blood Pressure Medication Requires Monitoring
One of the hardest parts of primary care is losing patients to follow-up. I understand how it happens. People are busy, schedules change, physicians leave, insurance becomes complicated, and patients who feel well may not see a reason to return.
Unfortunately, hypertension usually does not make people feel sick, even when it is causing damage. Nearly half of American adults have high blood pressure, yet many treated patients still do not reach recommended targets. Many patients need two or more medications to get there.
Home readings are especially useful. A single office measurement can be affected by stress, caffeine, pain, recent exercise, talking during the measurement, or rushing into the appointment. A series of properly taken readings at home gives me a much better picture. I generally want patients seated quietly with their back supported, feet flat on the floor, and arm resting at heart level. The cuff also needs to be the correct size.

Bloodwork matters too. ACE inhibitors and ARBs can raise potassium and affect kidney function. Diuretics can cause low sodium, low potassium, dehydration, gout, and changes in kidney function. Amlodipine and similar calcium-channel blockers can cause swelling in the ankles and legs. Excessive treatment can lead to dizziness, weakness, falls, or symptomatic low blood pressure. Depending on the medication and the patient, kidney function and electrolytes may need to be checked shortly after treatment begins or a dose is increased.
Follow-up also gives us an opportunity to reduce medication. If someone loses a meaningful amount of weight, starts exercising regularly, improves their diet, treats sleep apnea, or substantially reduces alcohol intake, the previous regimen may become more than they need. Using less medication is not a failure. The goal is to use the fewest medications necessary to control blood pressure safely and consistently.
4. I Like Medications That Can Do Two Jobs
I appreciate a good Swiss Army knife. When two medications are both reasonable options, I consider whether one might also help another medical problem.
Thiazide diuretics are one example. In addition to lowering blood pressure, they reduce the amount of calcium excreted in the urine. Because most kidney stones contain calcium, a thiazide may be useful in selected patients who have hypertension along with recurrent calcium stones and elevated urinary calcium. The evidence for exactly how much thiazides prevent recurrent stones is more complicated than it once appeared, so I would not prescribe one automatically to every patient with a history of stones. It can still be a useful advantage when the rest of the clinical picture fits.
Telmisartan is another interesting example. Like other ARBs, it blocks the angiotensin II receptor. It also has partial activity involving PPAR-gamma, a receptor involved in insulin sensitivity, glucose regulation, and fat-cell biology. Some studies have found modest improvements in metabolic measurements such as insulin sensitivity, triglycerides, or visceral fat.
Telmisartan is not a weight-loss medication, and I would never advertise it as one. The effect is nowhere near what we see with medications developed specifically for obesity. Still, if I am already choosing an ARB for a patient with hypertension and metabolic syndrome, those additional properties are interesting.
ACE inhibitors and ARBs can also serve a second purpose in patients with albuminuric chronic kidney disease. By reducing pressure within the kidney’s filtering system, they can lower blood pressure while helping slow the progression of kidney damage.
Even a beta-blocker can earn its place this way. I may not select one first for uncomplicated hypertension, but the decision changes if the same patient also has an arrhythmia requiring rate control, bothersome essential tremor, angina, or another clear indication.
The question is not simply, “What lowers blood pressure?” It is, “What makes the most sense for this particular patient?”
5. Complete the Cardiovascular Risk Picture
Blood pressure is only one part of cardiovascular risk. If I lower someone’s blood pressure to 128/76 while ignoring an LDL cholesterol of 190, uncontrolled diabetes, cigarette smoking, or heavy alcohol use, I have treated only part of the problem.
Cholesterol Still Matters
We are living through an unusual period of medical misinformation. A podcast clip, viral video, or personal anecdote can circulate more widely than decades of carefully accumulated evidence.
Cholesterol is a prime example. The connection between elevated LDL cholesterol and atherosclerotic cardiovascular disease is supported by population research, human genetics, pathology, and randomized clinical trials. The longer the arteries are exposed to elevated LDL particles, the greater the opportunity for plaque to develop. Lowering LDL in appropriately selected patients reduces the risk of heart attack and stroke.
Statins are also widely misunderstood. They are not perfect medications, and no responsible physician should pretend they are. Some patients develop muscle symptoms, liver enzyme abnormalities, increased blood sugar, or other adverse effects. At the same time, statins are among the most extensively studied medications in modern medicine. They are inexpensive, widely available, and supported by decades of evidence showing reductions in cardiovascular events.
Muscle symptoms are more complicated than either side of the online argument usually admits. True statin intolerance exists, but background aches and expectations about side effects can also influence which symptoms are attributed to a medication. In blinded studies, some patients who previously stopped statins because of symptoms developed nearly the same symptoms while unknowingly taking a placebo. The symptoms were real, but the statin was not always the cause.
When intolerance does occur, we have options. We can try a different statin, lower the dose, use intermittent dosing, or consider medications such as ezetimibe, bempedoic acid, or a PCSK9-targeting therapy. What concerns me is seeing a severely elevated LDL ignored because someone encountered frightening or misleading information online. Declining treatment does not make the underlying risk disappear. [3]
Diabetes and Smoking Affect the Same Blood Vessels
The inner surface of every blood vessel is lined by a layer of cells called the endothelium. It is not merely a passive lining. It helps regulate blood flow, inflammation, clotting, and the ability of arteries to relax.
Diabetes disrupts this system through chronically elevated glucose, insulin resistance, inflammation, and oxidative stress. Smoking damages it through many of the same pathways. Cigarette smoke decreases nitric oxide availability, activates platelets, increases inflammation, and promotes changes in the arterial wall that contribute to plaque formation.
These risks do not exist independently. Hypertension and smoking together are worse than hypertension alone. Add diabetes and markedly elevated LDL, and the environment within the arteries becomes even more favorable to atherosclerosis. This is why I do not want to spend an entire visit celebrating an improved blood pressure while ignoring everything else affecting the same blood vessels.
Alcohol, Exercise, and Nutrition
Alcohol also belongs in the conversation. The old idea that drinking, especially red wine, is inherently good for the heart is far too simplistic. Higher alcohol intake is associated with higher blood pressure and increased risks of atrial fibrillation, liver disease, and several cancers. In patients who drink heavily, reducing alcohol can sometimes improve blood pressure enough to avoid adding another medication.
Starting medication does not make exercise and nutrition less important. Regular physical activity improves blood pressure, insulin sensitivity, vascular function, cardiorespiratory fitness, and body composition. A diet centered on vegetables, fruits, legumes, whole grains, lean proteins, and minimally processed foods can improve blood pressure, cholesterol, glucose control, and weight at the same time.

The DASH eating pattern, sodium reduction, regular exercise, healthy weight loss, and reducing or eliminating alcohol remain central parts of modern hypertension treatment. Medication helps control one risk factor. It cannot reproduce everything that exercise, nutrition, sleep, and smoking cessation do for the body. [4]
The Bottom Line
Managing hypertension involves more than seeing an elevated number and prescribing another pill. I want to know whether the measurement is accurate, what the readings look like at home, why the pressure is elevated, and whether a secondary cause should be considered. If medication is needed, I want to know whether it is the right medication, whether it lasts throughout the day, whether it is helping or worsening another condition, and whether the kidneys and electrolytes are tolerating it.
I also want to know whether lifestyle changes could allow us to use less medication and whether focusing on blood pressure has distracted us from cholesterol, diabetes, smoking, weight, exercise, alcohol, and the rest of the patient’s cardiovascular risk.
The goal is not to create a nice number in the medical record. It is to reduce the risk of heart attack, stroke, kidney disease, and other complications while helping patients feel well and remain healthy for as long as possible. Sometimes that means starting medication, sometimes it means switching medication, and sometimes it means getting rid of medication. Every medication should have a reason behind it.
Sources
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2018;71(6).
- Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension. Journal of Hypertension. 2023;41(12):1874-2071.
- Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. European Heart Journal. 2017;38(32):2459-2472.
- Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension diet. The New England Journal of Medicine. 2001;344(1):3-10.
